Sixth Wave Innovations Dr Jon Gluckman on the colorimetric detection of SARS-CoV-2

In a recent InvestorIntel interview, Tracy Weslosky spoke with Dr. Jon Gluckman, President, CEO and Founder of Sixth Wave Innovations Inc. (CSE: SIXW | OTCQB: ATURF) about the successful demonstration of colorimetric detection of SARS-CoV-2, the virus that causes COVID-19 utilizing Sixth Wave’s Accelerated Molecular Imprinted Polymers (“AMIPs™”) technology.

In this InvestorIntel interview, which may also be viewed on YouTube (click here to subscribe to the InvestorIntel Channel), Dr. Gluckman went on to say that colorimetric detection is a method of identifying the presence of a target substance within a test sample by means of a color reagent. He added that the Company is evaluating the detection capabilities of the technology for all the active strains of SARS-CoV-2. Dr. Gluckman also provided an update on Sixth Wave’s letter of intent with Halucenex Life Sciences Inc. to explore a collaboration for the separation of compounds such as psilocybin, baeocystin, and others using molecularly imprinted polymers.

To watch the full interview, click here

About Sixth Wave Innovations Inc.

Sixth Wave is a nanotechnology company with patented technologies that focus on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs). The Company is in the process of a commercial rollout of its Affinity™ cannabinoid purification system, as well as, IXOS®, a line of extraction polymers for the gold mining industry. The Company is in the development stages of a rapid diagnostic test for viruses under the Accelerated MIPs (AMIPs™) label.

Sixth Wave can design, develop and commercialize MIP solutions across a broad spectrum of industries. The company is focused on nanotechnology architectures that are highly relevant for the detection and separation of viruses, biogenic amines, and other pathogens, for which the Company has products at various stages of development.

To learn more about Sixth Wave Innovations Inc., click here

Disclaimer: Sixth Wave Innovations Inc. is an advertorial member of InvestorIntel Corp.

This interview, which was produced by InvestorIntel Corp. (IIC) does not contain, nor does it purport to contain, a summary of all the material information concerning the Company” being interviewed. IIC offers no representations or warranties that any of the information contained in this interview is accurate or complete. 

This presentation may contain “forward-looking statements” within the meaning of applicable Canadian securities legislation.  Forward-looking statements are based on the opinions and assumptions of management of the Company as of the date made. They are inherently susceptible to uncertainty and other factors that could cause actual events/results to differ materially from these forward-looking statements. Additional risks and uncertainties, including those that the Company does not know about now or that it currently deems immaterial, may also adversely affect the Company’s business or any investment therein.

Any projections given are principally intended for use as objectives and are not intended, and should not be taken,  as assurances that the projected results will be obtained by the Company. The assumptions used may not prove to be accurate and a potential decline in the Company’s financial condition or results of operations may negatively impact the value of its securities. Prospective investors are urged to review the Company’s profile on and to carry out independent investigations in order to determine their interest in investing in the Company.

If you have any questions surrounding the content of this interview, please email

Will Sixth Wave help prevent a fourth wave?

Sixth Wave Innovations Inc. (CSE: SIXW | OTCQB: ATURF) is a nanotechnology company focused on extraction and detection of target substances at the molecular level. Their products can be very cost effective and potentially eliminate human error from the testing or measurement process. These advantages are derived from the application of patented technologies in the highly specialized field of molecularly imprinted polymers (MIPs).

Sounds pretty technical so what does that mean to you and me? As we battle a third wave of COVID-19 we are crossing our fingers and hoping vaccines will save the day. Especially given, that for all the talk about rapid testing, we have yet to see an effective, accurate test used in a broad setting to help identify or track the spread of the SARS-CoV-2 virus. And who knows if all the variants that are popping up will continue to be effectively subdued by existing vaccines.

Enter Sixth Wave and their patent pending Accelerated Molecular Imprinted Polymers (AMIPs™) technology. Last week the company announced it has successfully demonstrated colorimetric detection of SARS-CoV-2. Colorimetric detection is a method of identifying the presence of a target substance within a test sample by means of color. For example, Green = COVID-19, Blue = Influenza, Red = Rhinovirus. And yes, the test could potentially identify multiple viruses in a single pass with different colors for each. Even better, the AMIPs™ test does not require the use of biological materials which have the potential to result in errors (false positive or false negative). As well, the methodology utilized by AMIPs™ should be more robust in its ability to detect variants because the mechanism used to capture and immobilize the virus is not keyed to a specific Antigen-Antibody relationship. Lastly, this robust, reliable product should result in a lower cost, either to an individual requiring a test or a government trying to get a handle on this annoyingly resilient virus.

Imagine kids going back to school and they all have a mask utilizing Sixth Wave technology. All you need to do is check each student’s mask and if it’s green the child gets sent home otherwise they are good to go until the next day. Now what if everyone had a mask, or some other device with AMIPs™ technology, then everyone could get back to going to sporting events, concerts or weddings. Even air travel and cruise ships would be able to operate relatively seamlessly based on the individual not being green, so to speak. This could be the solution that gets us back to a semblance of normal.

Unfortunately, as good as this all sounds, Sixth Wave isn’t the answer to all our problems just yet. Next steps include building on this initial validation toward the development of a colorimetric sensor for a potentially wide range of rapid Virus detection devices using AMIPs™. As well, the Company is proposing to create a comprehensive library of molecular imprints for other viral pathogens and variants. This AMIP library will be capable of being licensed for all manner of rapid detection test (RDT) devices and wearables, such as a smart mask, smart clothing and PPE applications, airborne sensors, Breathalyzers, and others. The groundwork has been laid but it remains to be seen if the company can capitalize on its efforts.

Nevertheless, the company has its Affinity™ System which uses MIPs to deliver an innovative purification solution to the cannabis market. First revenue from cannabinoid extraction is expected in Q1/21. As well there is the IXOS product, a line of extraction polymers formulated for deployment in the gold mining industry for the extraction of gold from cyanide leach solutions. Sixth Wave is undertaking pilot plant testing of IXOS technology at a major gold producer (Kinross Gold Corporation). The company recently raised $6M via a private placement which should give them enough cash to continue developing and innovating its product base for another 6 months, give or take. It will be interesting to see if the company can start generating revenue to reduce the cash burn and advance all these exciting prospects.